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SP8 Transcriptional Regulation of
Cyclin D1 During Mouse Early
Corticogenesis
Ugo Borello 1,2*, Barbara Berarducci 1, Edwige Delahaye 1, David J. Price 3 and
Colette Dehay 1
1Université de Lyon, Université Claude Bernard Lyon 1, Inserm, Stem Cell and Brain Research Institute U1208, Bron, France,
2 Inovarion, Paris, France, 3Centre for Integrative Physiology, University of Edinburgh, Edinburgh, United Kingdom
Multiple signals control the balance between proliferation and differentiation of neural
progenitor cells during corticogenesis. A key point of this regulation is the control of G1
phase length, which is regulated by the Cyclin/Cdks complexes. Using genome-wide
chromatin immunoprecipitation assay and mouse genetics, we have explored the
transcriptional regulation of Cyclin D1 (Ccnd1) during the early developmental stages
of the mouse cerebral cortex. We found evidence that SP8 binds to the Ccnd1 locus
on exon regions. In vitro experiments show SP8 binding activity on Ccnd1 gene 3′-end,
and point to a putative role for SP8 in modulating PAX6-mediated repression of Ccnd1
along the dorso-ventral axis of the developing pallium, creating a medialLow-lateralHigh
gradient of neuronal differentiation. Activation of Ccnd1 through the promoter/5′-end of
the gene does not depend on SP8, but on βcatenin (CTNNB1). Importantly, alteration of
the Sp8 level of expression in vivo affects Ccnd1 expression during early corticogenesis.
Our results indicate that Ccnd1 regulation is the result of multiple signals and that SP8 is
a player in this regulation, revealing an unexpected and potentially novel mechanism of
transcriptional activation.
Keywords: corticogenesis, gene expression regulation, Cyclin D1, transcription factors, SP8, PAX6
INTRODUCTION
The cerebral cortex is the most complex structure of the mammalian brain. It is the site of
numerous higher-order sensory, motor, and cognitive functions. Cortical function relies on the
proper formation of specialized cortical areas as well as on their sophisticated interconnections
(Glasser et al., 2016).
During development, regionalization of the embryonic brain is achieved through multi-step
processes. Sources of diffusible signaling molecules act as organizing centers and pattern
neighboring domains through regulation of specific transcription factors expression, thereby
creating molecular compartments that lead to the generation of distinct cortical fields (Rubenstein
et al., 1998; Sur and Rubenstein, 2005; O’Leary et al., 2007).
Cortical projection neurons are generated in the germinal zones (GZ) of the dorsal
telencephalon and, following cell-cycle exit, migrate radially to the cortical plate. Previous work
has shown that regional differences in the proliferative programs in the GZ have far reaching
consequences for histogenesis of cortical areas (Dehay et al., 1993; Polleux et al., 1997; Lukaszewicz
et al., 2005).
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Neuron number and types specific of each cortical layer and
area are defined by the fine-tuned balance between proliferation
and differentiation of cortical progenitor cells. While cell
biology mechanisms underlying the switch from proliferative
to differentiative divisions have been identified (Fish et al.,
2006; Delaunay et al., 2014, 2017; Mora-Bermudez et al., 2014;
Paridaen and Huttner, 2014; Matsuzaki and Shitamukai, 2015), it
has been shown that the increasing fraction of progenitor cells
that quit the cell cycle to embark on neuronal differentiation
correlate with a lengthening of the G1 phase of the cell cycle
(Takahashi et al., 1995; Calegari et al., 2005; Salomoni and
Calegari, 2010; Arai et al., 2011). G1 phase is considered as a time
window of susceptibility to differentiation signals (Mummery
et al., 1987) and G1 phase lengthening increases the competence
of a proliferating cell to withdraw from the cell cycle and to
differentiate (Zetterberg et al., 1995).
During corticogenesis, proliferative and differentiative
divisions are characterized by short and long G1 phases
respectively (Dehay et al., 2001; Lukaszewicz et al., 2002,
2005; Calegari and Huttner, 2003; Dehay and Kennedy,
2007; Pilaz et al., 2009). Progression through G1 phase is
regulated mainly by the kinase activity of Cyclin D/CDK4
and Cyclin E/CDK2 (Sherr and Roberts, 2004), both of which
have been shown to play a key role in determining neuron
number during mouse mid-corticogenesis (Lange et al., 2009;
Pilaz et al., 2009). In particular, Cyclin D1 (Ccnd1) dynamic
expression levels have been shown to be at the heart of a
regulatory network that control the balance between cortical
progenitor proliferation and differentiation (Ghosh et al.,
2014).
Here we have explored the transcriptional regulation of
Ccnd1 expression during early corticogenesis. Numerous
transcriptional factors binding to the Ccnd1 promoter have
been identified (Klein and Assoian, 2008). It is targeted by
TCF/βcatenin complex (Shtutman et al., 1999; Tetsu and
McCormick, 1999), effector of the Wnt pathway, which plays
a key role in regulating cortical expansion (Chenn and Walsh,
2003). More recently, it has been reported that the transcription
factor PAX6, known to regulate proliferation and differentiation
of cortical progenitors (Warren et al., 1999; Estivill-Torrus et al.,
2002; Quinn et al., 2007; Sansom et al., 2009; Mi et al., 2013)
binds to the Ccnd1 locus (Sun et al., 2015).
PAX6 plays a key role in forebrain patterning and cortex
arealization (Stoykova et al., 1997; Bishop et al., 2000, 2002;
Muzio et al., 2002; Englund et al., 2005). Interestingly, Pax6
shows a complementary expression pattern to the transcription
factor Sp8 in the developing pallium with a rostro-ventralHigh
gradient (Sahara et al., 2007; Borello et al., 2014). SP8 is
a zinc finger transcription factor belonging to the Sp-family
of transcription factors (Zhao and Meng, 2005). SP8 acts
downstream of FGF8 signaling (Storm et al., 2006), regulates
forebrain patterning and cortical arealization (Sahara et al., 2007;
Zembrzycki et al., 2007; Borello et al., 2014), and regulates
cortical progenitor cell differentiation (Borello et al., 2014).
Interestingly, SP5/SP8 have been shown to act as co-activators
of the Wnt pathway in mouse embryos and differentiating
embryonic stem (ES) cells (Kennedy et al., 2016).
We have therefore sought to analyze the putative role of
SP8, together with PAX6 and βcatenin, on the transcriptional
control of Ccnd1. Our ChipSeq and mouse genetics analysis
reveal that Ccnd1 is a target gene of SP8. We show that SP8 is
a critical player in the regulation of Ccnd1 expression during
in vivo mouse corticogenesis. SP8 is able to modulate the
moderate repressive transcriptional activity exerted by PAX6 on
the Ccnd1 exon 1 region in vitro. By contrast, we did not observe
cooperation between SP8 and βcatenin on Ccnd1 activation from
the promoter/5′end of the gene. Finally, we demonstrate that SP8
is able to specifically activate gene expression from the Ccnd1
exon 5 fragment, containing part of the 3′UTR, suggesting that
the 3′-end of the Ccnd1 gene may be target of gene regulation at
multiple levels, including transcription.
MATERIALS AND METHODS
Animals
Foxg1tTA+/− and tetO-Sp8-IE mice (Waclaw et al., 2009),
Foxg1cre (Hebert and McConnell, 2000) and Sp8fl/fl (Waclaw
et al., 2006) mice were maintained and genotyped as already
described (Waclaw et al., 2006, 2009, 2010). Mouse colonies were
maintained at the SBRI/INSERM U1208, in accordance with the
European requirement for animal experimentation 2010/63/UE.
The protocol APAFIS #4748 has been approved by the Animal
Care and Use Committee CELYNE (C2EA #42).
Histology and in Situ RNA Hybridization
(ISH)
Embryos were collected considering noon on the day of
the vaginal plug as E0.5. The embryos were dissected and
fixed overnight by immersion in 4% paraformaldehyde (PFA)
in phosphate buffered saline (PBS) at 4◦C. The tissue was
cryoprotected by immersion in 30% sucrose/PBS, embedded in
OCT (Tissue-Tek), and cryostat sectioned at 20µm.
In situ RNA hybridization on cryostat sections was performed
as previously described (Borello et al., 2008). cRNA probes
used were: Sp8 (K. Campbell, Cincinnati Children’s Hospital,
OH, USA), Ccnd1 (A. Mallamaci, SISSA, Trieste, IT), Axin2
(B. Cheyette, UCSF, USA), and Pax6 (D. Price, University of
Edinburgh).
Gene expression patterns were compared between brains of
different genotypes by matching the plane of section according
to multiple anatomical features. Whenever possible, this was
performed for multiple planes of sections for each gene, and from
at least three brains for each genotype.
Foxg1tTA/+ and the tetO-Sp8-IE mice were used as control;
differences in phenotype were not observed between these two
lines or between Foxg1tTA/+ and the tetO-Sp8-IE mice and the
wild type embryos.
ChipSeq
Dorsal telenchephalon (pallium) was dissected from E12.5
CD1 mouse embryos. The cells were crosslinked with 1%
formaldehyde for 10min. The formaldehyde reaction was
quenched by adding glycine to a final concentration of 0.125M
for 10min. Cells were then pelleted, rinsed once in cold
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phosphate-buffered saline (PBS) with 1mM PMSF and once in
cold lysis buffer (10mM Tris pH 7.5, 10mMNaCl, 3mMMgCl2,
0.5% NP-40, and Roche Complete Protease Inhibitor Cocktail)
to obtain nuclear pellets. Nuclei were sonicated in RIPA buffer
(1X PBS, 1% NP-40 Substitute, 0.5% Sodium Deoxycholate,
0.1% SDS, and Roche Complete Protease Inhibitor Cocktail)
at a concentration of 5 × 107 nuclei/mL using a diagenode
sonicator (Bioruptor Plus). The DNA fragments bound by SP8
were isolated using a goat polyclonal anti-SP8 antibody (C-18,
Santa Cruz Biotechnology), a rabbit polyclonal anti-SP8 antibody
(ab739494, abcam), or rabbit polyclonal H3K27ac (ab4729,
abcam) coupled to magnetic beads (Dynabeads, ThermoFisher).
The beads were washed 5 times with LiCl Wash Buffer (100mM
Tris pH 7.5, 500mM LiCl, 1% NP-40, 1% sodium deoxycholate)
and finally with TE buffer (10mM Tris-HCl pH 7.5, 0.1mM
Na2EDTA).
The DNA was incubated o/n at 65◦C in elution buffer (1%
SDS, 0.1M NaHCO3) to reverse the formaldehyde crosslink and
was purified using a QIAquick PCR Purification Kit (Qiagen),
following the manufacturer protocol. To check for fragment
size distribution after sonication, a small fraction of the sample
was reverse cross-linked for 2 h at 65◦C, purified using DNA
purification columns fromQiagen, then loaded onto a 2% agarose
gel.
Sequence base calls were made using standard Illumina
methods. Resulting 1 × 50 bp sequences were filtered to remove
sequencing artifacts and adaptors and then mapped to the mouse
genome (mm9) using the BWA algorithm (Li and Durbin,
2009). The resulting uniquely mapped reads were used for
peak calling with MACS1.4 for SP8 and MACS2.1 for H3K27ac
(Zhang et al., 2008; Feng et al., 2011), using recommended
settings for transcriptional factor analysis and histone marks
respectively. Called peaks were filtered to remove regions where
a significant number of artifacts could originate (Consortium,
2012) (https://sites.google.com/site/anshulkundaje/projects/
blacklists). Pearson’s correlation on the two replicates calculated
with a call to wigCorrelate (http://hgdownload.soe.ucsc.edu/
admin/exe/macOSX.x86_64/) or Wiggletools (Zerbino et al.,
2014) gave a value of 0.9. Peaks were annotated based on nearest
transcription start site (TSS) using the Bioconductor package
ChiPpeakAnno (Zhu et al., 2010) and ChiPseeker (Yu et al.,
2015) and visualized using the Gviz package (Hahne and Ivanek,
2016).
The SP8 ChipSeq data presented in the “Results” section were
obtained using the goat polyclonal anti-Sp8 antibody. These
results were confirmed with a SP8 ChipSeq performed on two
other independent biological replicates with the rabbit polyclonal
anti-Sp8 antibody (Table S1 and data not shown).
Cell Transfection and Luciferase Assay
P19 cells (ATCC number: CRL-1825) were maintained in
growth medium: Alpha Minimum Essential Medium with
ribonucleosides and deoxyribonucleosides (ThermoFisher)
completed with 7.5% bovine calf serum and 2.5% fetal calf
serum (ThermoFisher) (McBurney and Rogers, 1982; McBurney
et al., 1982). The cells were transfected with the expression
vector for the full-length cDNA of human βcatenin (gifts of Dr
Grosschedl, Max Planck Institute of Immunology, Germany),
or Pax6 (D. Price, University of Edinburgh, UK), or Sp8 (gift
of K. Campbell, Cincinnati Children’s Hospital, OH, USA),
along with the different Ccnd1 fragments identified by ChipSeq
(Table S1), cloned in the pGL4.10[Luc2] vector (Promega)
containing the human βglobin minimal promoter upstream
of the luciferase gene (Luc2, Photinus pyralis). The fragment
named Ccnd1 exon 2.3 contains Ccnd1 exons 2 and 3. The vector
pG4.74[hRLuc/TK] (Promega), containing the Renilla luciferase
gene, was co-transfected for normalization. The TK promoter of
the pG4.74[hRLuc/TK] vector was substituted with the human
βglobinminimal promoter (from vector BGZ40) (Yee and Rigby,
1993).
The cells were transfected with Lipofectamine 2000
(ThermoFisher) in OPTIMEM medium (ThermoFisher)
following the manufacturer’s instructions, and cultured after 6 h
in growth medium. Twenty-four hours after the transfection
the cells were harvested in lysis buffer (Promega), and the
luciferase and renilla luciferase activities were measured using
the Dual Luciferase Assay protocol (Promega). Each transfection
experiment was performed in triplicate and repeated at least two
times. Reporter gene activities shown in Figures 3–5 represent
the average of the three replicates obtained in one representative
transfection experiment. Statistical analysis was performed using
the statistical package R and ANOVA analysis was performed
using the “aov” R function and Tukey multiple comparison test.
p< 0.05 were considered statistical significant.
RESULTS
Cyclin D1 Is Expressed in the
Developing Forebrain at E12.5 With
a Rostro-VentralHigh Gradient
Cyclin D1 is a key regulator of G1 phase progression in neural
progenitor cells. We analyzed the mRNA expression of Cyclin
D1 in the embryonic forebrain at E12.5. We found that while
Ccnd1 is strongly expressed in the ventricular zone (VZ) of the
basal ganglia (Figures 1A,B, arrowheads), its expression in the
pallial VZ follows a rostro-lateralHigh gradient (Figures 1A–C).
In particular, Ccnd1 expression is low in the medial pallium
compared to dorsal and lateral regions (Figure 1A, arrow), while
it is not expressed caudally in the hem (Figure 1B, arrow). This
shows that Ccnd1 is not expressed in all pallial progenitor cells
at the same level, suggesting that the complex Ccnd1 expression
pattern is regulated by different factors.
Sp8 is expressed in the pallium with a rostro-medialHigh
gradient (Figures 1D–F). Sp8 is expressed in the pallial
VZ, as Ccnd1. In the subpallium Sp8 is expressed in the
subventricular zone (SVZ) of the lateral ganglionic eminence
(LGE) (Figures 1D,E, arrowheads), while Ccnd1 is expressed in
the subpallial VZ (Figures 1A,B, arrowheads).
Ccnd1 appears to be highly expressed in the dorsal pallium
were Sp8 expression is high (Figures 1A,B,D,E, asterisks);
interestingly Ccnd1 expression is lower in the medial pallium, a
region of strong Sp8 expression (Figures 1A,B,D,E, arrows).
In conclusion, the expression pattern of Sp8 is compatible with
the possibility that it contributes to the transcriptional regulation
of Ccnd1 in the dorso-medial pallium.
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FIGURE 1 | Ccnd1 and Sp8 expression patterns at E12.5. ISH performed on E12.5 mouse forebrain coronal sections. Panels (A,B) show Ccnd1 mRNA expression;
Panels (D,E) indicate Sp8 mRNA expression. Schematic of Ccnd1 (C) and Sp8 (F) gradients of expression are indicated along with the positions of sections shown in
(A–D). Panels (A,D) represent sections at the rostral level, while Panels (B,E) represent sections at the caudal level. Arrows point to the medial pallium; arrowheads
indicate the VZ (A,B) or the SVZ of the LGE (D,E). The asterisk indicates the dorsal pallium. Bar in panel (A) is 200µm. Ro, rostral; Ca, Caudal.
The Zinc Finger Transcriptional Factor SP8
Binds to the Ccnd1 Locus in Cortical
Progenitor Cells
To test the hypothesis that SP8 regulates Ccnd1 at the
transcriptional level, we performed SP8 ChipSeq experiments
using E12.5 mouse embryos pallial cells (manuscript in
preparation). We found that SP8 binds the Ccnd1 locus in vivo
decorating Ccnd1 exons (Figures 2A,B), with higher values for
exon 1 containing the 5′UTR, exon 2, and exon 5 containing part
of the 3′UTR.
The presence of acetylated histone H3 lysine 27 (H3K27ac) on
exons 1 and 2 indicated that these regions correspond to active
chromatin domains (Figures 2C,D). The Ccnd1 exon 5 and exon
3 co-localize with the H3K27ac signal, even though it is of smaller
intensity than in the exon 1 (Figures 2C,D). H3K27ac signals
were obtained from ChipSeq experiments using, as for SP8, E12.5
mouse pallial cells (data not shown, manuscript in preparation).
The fact that Ccnd1 5′UTR showed H3K27ac signal and it
contains a CpG island suggests a role for this region in the
transcriptional regulation of Ccnd1 in E12.5 cortical progenitor
cells (Figures 2C,D). Moreover, Ccnd1 promoter and the 3′UTR
represent important regulative regions for the transcriptional
regulation of this gene (Klein and Assoian, 2008; Deshpande
et al., 2009; Guo et al., 2011). Together these data indicate that
SP8 binds transcriptionally active regions in the Ccnd1 locus
in vivo in pallial progenitor cells.
SP8 Regulates Gene Expression Through
Ccnd1 Exon 5 Fragment in Vitro
The observation that SP8 binds mainly on Ccnd1 exons is
intriguing. It is generally assumed that the coding genome is
physically distinct from the regulatory genome. Consequently,
the binding of transcription factors to gene exons is considered
generally non-functional (Li et al., 2008). Therefore, we evaluated
the relevance of SP8 binding on Ccnd1 exons observed in our
ChipSeq experiments.
To test the transcriptional activity of SP8 on the different
Ccnd1 exons we performed a luciferase assay in vitro. We focused
on the Ccnd1 exons showing both SP8 ChipSeq peaks and active
chromatin signature (i.e., H3K27ac signal) (Figure 2). The exon 1
(Ex1) fragment contained the last 293 bp of the Ccnd1 promoter
(Eto, 2000), the entire exon 1 (containing the 5′UTR) and the
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FIGURE 2 | SP8 binding regions on the Ccnd1 locus. Panels (A,B) show SP8 ChipSeq peaks in input and SP8 antibody (Ab) treated samples respectively. Panel (C)
shows normalized H3K27ac ChipSeq peaks. Panel (D) shows Ccnd1 RefSeq gene model in light gray, the promoter (Eto, 2000) in dark gray, and the CpG islands in
green. Sp8 exons are numbered and the UTRs are indicated.
first 526 bp of intron 1 (Figure 2 and Figure S1). The exon 5
(Ex5) fragment spanned from intron 4 (last 425 bp) to the
coding region up to the first 299 bp of the 3′UTR (Figure 2 and
Figure S2).
The DNA region corresponding to the SP8 ChipSeq peaks
were cloned upstream of the luciferase gene and tested
in P19 cells in the presence of increasing levels of SP8.
Surprisingly, we found that SP8 had no activity on the Ccnd1
Ex1 fragment (Figures 3A,B), nor on exons 2 and 3 (Ex2.3)
fragment (Figures 3C,D). However, increasing amounts of SP8
activated the luciferase gene through the Ccnd1 Ex5 fragment
(Figures 3E,F).
Bioinformatic analysis using the Jaspar software, indicated 7
putative SP8 binding sites located in the Ex5 fragment (Table S2);
specifically, a cluster of 6 sites is located in the exon 5 ORF
(Figure S2). This region contains the SP8 peak summit identified
in our ChipSeq results (Figure 5 and Figure S2). This unexpected
result indicates that SP8 binds to the exonic region 5 of Ccnd1,
thereby modulating its transcription.
βcatenin and PAX6 Regulate Ccnd1 Exon1
Fragment Activity in Vitro
The Wnt/βcatenin pathway was demonstrated to be a major
regulator of Ccnd1 gene expression (Shtutman et al., 1999;
Tetsu and McCormick, 1999). The Wnt pathway regulates gene
expression by binding of the cofactor βcatenin to genomic
regulative regions specifically recognized by TCF/LEF, the
effectors of theWnt pathway (Clevers, 2006; van Amerongen and
Nusse, 2009).
Interestingly, the SP8 ChipSeq peak corresponding to exon
1 and containing the last 293 nucleotides of the mouse Ccnd1
promoter (Eto, 2000), contains a highly conserved consensus
for TCF/LEF transcriptional factors (Klein and Assoian, 2008)
(Figure 4A). As in human, mouse Ccnd1 promoter has no TATA
or TATA-like sequence, and the TSS is determined by the Initiator
sequence (Inr) (Eto, 2000). However, two possible Inr sequences
are present in the mouse Ccnd1 promoter, the second one located
at nt+90 from the first Inr sequence, determining a TSS at nt+96
(Eto, 2000) (Figure 4A). According to the Inr site described by
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FIGURE 3 | SP8 transcriptional regulation of Ccnd1 genomic regions bound by Sp8. Panels (A,C,E) show details of the Ccnd1 locus where the SP8 ChipSeq peak
have been detected: (A) SP8 peak at the Ccnd1 Ex1 fragment; (C) SP8 peak at the Ccnd1 Ex5 fragment; (E) Sp8 peak at the Ccnd1 Ex2.3 fragment. 1: SP8 Chip
(Continued)
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FIGURE 3 | input peaks, 2: SP8 Chip peaks, 3: H3K27ac Chip Input peaks, 4: H3K27ac Chip peaks, 5: CpG island, 6: Ccnd1 RefSeq gene model. For details refer to
the legend of Figure 2. Panels (B,D,F) show the results of the luciferase assays performed with Ccnd1 Ex1 (B), Ccnd1 Ex2.3 (F), and Ccnd1 Ex5 (D) fragments.
Statistical significance, ANOVA: *p < 0.05, **p < 0.01.
FIGURE 4 | βcatenin and PAX6 transcriptional regulation of Ccnd1 regulative
regions identified by SP8 ChipSeq. (A) represents the schema of the 5′ portion
of the exon 1 fragment. The transcriptional start sites, TSS1 and TSS2, the
first codon ATG, and the conserved βcatenin binding site (Klein and Assoian,
2008), and the SP8 summit (SP8S) positions are indicated. The 5′UTR region
is depicted in black; the ORF of exon 1 is indicated in white. Panel (B) shows
the results of the luciferase assay obtained from one representative
experiment. P19 cells were transfected with the Ccnd1 exon fragments
identified by SP8 ChipSeq alone or in combination with βcatenin, SP8, or
βcatenin together with SP8. Statistical significance, ANOVA: **p < 0.01,
***p < 0.001.
Eto (2000), the conserved TCF/LEF site is located downstream to
the first TSS, starting at nt+ 14, in theCcnd1 5′UTR (Figure 4A).
We tested βcatenin transcriptional activity in combination
with SP8 on the above described Ccnd1 fragments. We used a
constitutively active form of βcatenin that is not degraded by
the proteasome and accumulates into the nucleus (Hsu et al.,
1998) in a luciferase assay in vitro. Our results showed that
βcatenin activates luciferase transcription specifically through
the Ccnd1 Ex1 fragment, and that SP8 does not modulate this
effect (Figure 4B). No effect was observed on Ccnd1 Ex2.3 or Ex5
fragments (Figure 4B).
PAX6 is a transcription factor which regulates forebrain
patterning and growth. It is expressed with a complementary
gradient to that of Sp8 (Figures S3A,B). PAX6 binds to the
Ccnd1 locus (Sun et al., 2015). When we compared the position
of the PAX6 ChipSeq peak with that of SP8, we found that
the two transcription factors bind to an overlapping region in
the Ex1 fragment and that the SP8 peak summit was located
near the PAX6 binding region (Figures 5A,B and Figure S1).
Bioinformatics analysis using the Jaspar database showed a
potential PAX6 binding site in the Ex1 fragment at position+ 392
from the first TSS (Figure 5C and Figure S1); this predicted
consensus sequence is near the summit of the PAX6 ChipSeq
peak (Figure S1) (Sun et al., 2015).
We tested the effect of PAX6 on Ccnd1 Ex1 fragment
transcriptional activity and the effect of SP8 upon co-expression.
Our results showed that PAX6 exerts a moderate repressive
transcriptional activity on the Ccnd1 exon 1 region, and that
SP8 counteracts this repression when co-transfected with PAX6
(Figure 5D).
SP8 Regulates Ccnd1 During in Vivo
Corticogenesis
To further test the role of SP8 on Ccnd1 gene regulation we
analyzed the relevance of our in vitro results by altering the
level of Sp8 expression in vivo during corticogenesis. For this
purpose, we took advantage of genetic systems in which Sp8
was either overexpressed or absent. In the Sp8 gain-of-function
(GOF) transgenic mouse system, Sp8 is over-expressed during
forebrain development (Waclaw et al., 2009; Borello et al., 2014),
while in the loss-of-function (LOF) transgenic mouse system
(Waclaw et al., 2006; Borello et al., 2014), Sp8 expression is
eliminated (Figure S4).
When we analyzed Ccnd1 expression during early
corticogenesis using these genetic tools we found that Ccnd1
expression was strongly increased after Sp8 over-expression in
the GOF mutant mice (Figures 6A,B), while it was strongly
reduced in the LOF mutant mice in regions corresponding to
the higher Sp8 expression domain, i.e. the rostral dorso-medial
pallium (Figures 6A–C).
These data were further confirmed by RNASeq experiments
(data not shown) performed on E12.5 mouse pallial cells showing
an increase of Ccnd1 expression in the Sp8 GOF mutants of 3
folds (FDR adjusted p< 0.001) and a reduction of 0.8 folds in the
Sp8 LOF mutants (FDR adjusted p-value 0.09) (Table S3).
These findings indicate that SP8 is a critical player in the
regulation of Ccnd1 expression during mouse corticogenesis
in vivo.
DISCUSSION
Cyclin D1 is a major cell-cycle regulator (Ekholm and Reed,
2000; Sherr and Roberts, 2004) and has been shown to be at the
heart of a regulatory network controlling the balance between
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FIGURE 5 | PAX6 transcriptional regulation of Ccnd1 regulative regions. Panel (A) shows the schema of Ccnd1 locus. PAX6 [Chip peak fragment indicated in Sun
et al. (2015)], SP8 (Chip peak summit ±50 bp), βcatenin binding sites, and the TSS (named TSS1) described in Eto (2000) are depicted together with Ccnd1 exon 1
first codon (ATG) and the TSS reported by the RefSeq gene model (TSS2, red line on the RefSeq track). Panel (B) represents the schema of the SP8 and PAX6 peaks
positions on the Ccnd1 locus, showing the overlap between the SP8 (this work) and PAX6 ChipSeq peaks (Sun et al., 2015) on Ccnd1 Ex1 fragment. 1: SP8 Chip
peaks, 2: PAX6 chipped fragment, 3: Ccnd1 RefSeq gene model. The gray box on the Pax6 fragment is the PAX6 binding summit shown in (A). Panel (C) shows a
schematic of βcatenin, SP8 and PAX6 sites position on the 5′ portion of the exon 1 fragment. The PAX6 (PAX6S) and SP8 (SP8S) summit positions [indicated as the
central nt of the Chip-qPCR fragment indicated in Sun et al. (2015) and the calculated ChipSeq summit respectively] are indicated. The TSS described in Eto (2000)
(TSS1), the Ccnd1 first codon (ATG), and the TSS reported by the RefSeq gene model (TSS2) are also shown. The 5′UTR is depicted in black. Panel (D) shows the
luciferase assay results obtained from one representative experiment. Ccnd1 exon 1 was transfected in P19 cells alone or in combination with PAX6, SP8, and PAX6
together with SP8 (SP8_PAX6). Statistical significance, ANOVA: ***p < 0.001, **p < 0.01.
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FIGURE 6 | Expression of Ccnd1 in embryonic forebrain after Sp8 misexpression in vivo. ISH on E12.5 mouse forebrain coronal sections. Arrow in Panel (A) shows
Ccnd1 expression in the control pallial VZ. Arrows in Panels (B,C) show Ccnd1 expression in the Sp8 GOF and Sp8 LOF pallial VZ respectively. Bar in (A): 200µm.
proliferation and differentiation in the cerebral cortex (Ghosh
et al., 2014).
βcatenin is one of the main regulators of Ccnd1 expression
(Shtutman et al., 1999; Tetsu and McCormick, 1999; Klein and
Assoian, 2008). Our observations that Ccnd1 expression signal
does not necessarily correlate to regions of high Wnt/βcatenin
activity during early in vivo corticogenesis is consistent with
the idea that activation of the Ccnd1 gene might be modulated
by cooperation with other transcription factors. Indeed, Axin2,
a direct target and recognized proxy of the Wnt/βcatenin
pathway activity (Yan et al., 2001; Jho et al., 2002; Lustig et al.,
2002; Kim et al., 2007; Al Alam et al., 2011; van Amerongen
et al., 2012; Bowman et al., 2013), is strongly localized in the
medial pallium where Ccnd1 expression is low or absent and
weakly expressed in the dorsal pallium where Ccnd1 is highly
expressed (Figures 1A,B and Figures S3C,D). Altogether these
data suggest that while βcatenin regulates Ccnd1 expression
during corticogenesis in vivo, other transcription factors are also
at work to produce the observed Ccnd1 expression pattern in the
dorso-medial pallium.
Sp8 and Ccnd1 expression patterns in the early mouse
corticogenesis in vivo are consistent with a potential role of
SP8 on Ccnd1 gene regulation. The present data confirm this
hypothesis and show the identification of Ccnd1 as the first SP8
target gene.
SP8 binds on the Ccnd1 locus on regions of active chromatin,
as indicated by the H3K27ac ChipSeq results. Interestingly, peaks
with higher intensity were positioned at the promoter/exon1
region, and in exon 5, containing also the first 299 bp of the
3′UTR. Our findings were further confirmed by results from SP8
ChipSeq experiments using a second SP8 antibody (Table S1 and
data not shown). When we tested the responsiveness of these
regions to SP8 we found that SP8 was able to activate gene
expression from the Ccnd1 Ex5 but not from the Ex1 fragment,
containing the last 293 nucleotides of the Ccnd1 promoter.
These results are unexpected. The regulatory regions of the
genome are generally considered to localize outside of the
coding sequences to keep the regulatory and the coding codes
separated. However, a theoretical study predicts that the human
genome, compared to a synthetic string of DNA letters, could
accommodate short functional regulatory motifs in the protein
coding regions (Itzkovitz and Alon, 2007). In addition, different
studies aimed at identifying regulatory regions in the genome
found that a small percentage of these regulatory domains are
located in the coding sequences (Cawley et al., 2004; Visel et al.,
2009) and that they are functional (Ritter et al., 2012). Recently,
a comprehensive study mapping transcription factor binding on
human genome exons in many cells lines found that ∼15% of
human codons specify both amino acids and transcription factor
binding sites (Stergachis et al., 2013). Stergachis and colleagues
suggest the fascinating hypothesis that the transcription factors
binding to conserved sequences inside a gene exons have a role
in codon choice and protein evolution. Numerous studies report
that intergenic regulative regions like enhancers are sites of active
transcription (De Santa et al., 2010; Kim et al., 2010; Natoli and
Andrau, 2012; Shlyueva et al., 2014; Kim and Shiekhattar, 2015;
Li et al., 2016), blurring the distinction between transcribed gene
regions and regulative domains.
The Sp-family transcription factors bind preferentially GC
and/or GT-reach regions in TATA-containing and TATA-less
promoters and stimulate transcription by associating with the
basal transcription complex and other transcription factors
(Lania et al., 1997; Philipsen and Suske, 1999; Zhao and Meng,
2005). Consistently, the SP8 ChipSeq experiments showed that
78% of SP8 peaks correspond to gene promoters while genome
wide SP8 binds only∼2% of gene exons and UTRs (see Figure S5
for details on the genome-wide SP8 binding localization).
Interestingly, while our bioinformatics analysis identified several
SP8 binding sites in the Ccnd1 promoter contained in the Ex1
fragment (Table S4 and Figure S1), the ChipSeq experiment
indicates that the SP8 summit is located in the coding region. We
hypothesize that SP8 binding on Ccnd1 exons is related to the
fine-tuned regulation of Ccnd1 transcription, probably through
a precise chromatin 3D structure, as well as to Ccnd1 mRNA
maturation. There is also the possibility that SP8 is part of an
epigenetic complex regulation of Ccnd1 locus replication
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and transcription. These questions will require further
investigations.
Of interest, PAX6, which generally colocalizes with enhancers,
binds Ccnd1 exon 1 (Sun et al., 2015). The predicted PAX6
binding site starts at position + 392 from the TSS (166
nucleotides downstream to the ATG), (Figures 2, 5A–C and
Figure S1). Interestingly, while SP8 failed to directly regulate
Ccnd1 Ex1 fragment expression, we show that SP8 was able
to counteract the repressive activity exerted by PAX6 on the
Ccnd1 Ex1 fragment in vitro. Moreover, the repressive activity we
observed with PAX6 is consistent with the moderate increase of
Ccnd1mRNA observed in the Pax6 LOF E12.5 mutant forebrain
(Mi et al., 2013; Sun et al., 2015).
SP8 could, therefore, interfere with PAX6 effect on Ccnd1
expression. It is possible that, due to the close proximity of the
SP8 and PAX6 consensus, the two transcription factors compete
for the binding on Ccnd1 exon 1. As mentioned above, Sp8
and Pax6 show opposite gradient of expression during early
corticogenesis. At mid-gestation when Pax6 expression becomes
homogeneous in the pallium, Sp8 expression is expressed at low
levels. These data suggest that Ccnd1 is activated differentially
by Sp8 and Pax6 in opposite domains of the pallium and is
modulated by PAX6 and SP8 dosages along the neurogenic
gradient.
SOX2 activates Ccnd1 in a dose-dependent manner during
corticogenesis (Hagey and Muhr, 2014). SOX2, binding on
different sites on the Ccnd1 locus and interacting with the
TCF/βcatenin complex, regulates Ccnd1 expression and cortical
progenitor cell mode of division and rate of differentiation
(Hagey and Muhr, 2014). Considering the Sp8 graded expression
in the pallial VZ and the strong Sp8 expression in the subpallial
SVZ (Waclaw et al., 2006; Borello et al., 2014), one can
hypothesize that a dose-dependent differential transcriptional
regulation is also operant for SP8 (Figure 7).
In contrast to PAX6, βcatenin was able to activate
transcription from the Ccnd1 5′UTR, and this activation
was not dependent or modulated by SP8. The mouse Ccnd1
FIGURE 7 | Schema of the SP8, PAX6, and βcatenin interactions on the
mouse Ccnd1 gene. Panel (A) shows Sp8 and Pax6 expression gradients in
the developing mouse cortex. Panel (B) summarizes differences in Sp8 and
Pax6 expression levels along the medio-lateral axis of the pallium. Panel (C) is
a graphical representation of SP8, PAX6, and βcatenin binding positions on
Ccnd1 locus. R, Rostral; C, Caudal; M, Medial; L, Lateral.
Ex1 fragment described here contains a TCF/LEF consensus
that is conserved among different species, including human
(Klein and Assoian, 2008), suggesting a critical and fundamental
role for this site in Ccnd1 regulation. In addition, Tetsu and
colleagues showed that activation of the CCND1 human
minimal promoter,−962CD1 (Albanese et al., 1995), by βcatenin
depends on the presence of TCF binding sites but not of other
transcription factors (Tetsu and McCormick, 1999). These
observations are in agreement with our results showing that the
exon 1 fragment, containing only the last 293 nucleotides of
the mouse Ccnd1 promoter, was sufficient to support βcatenin
activity. The fact that βcatenin activity was independent of
SP8 indicates that these two transcription factors do not
cooperate by binding the Ccnd1 exon 1 region. However, a
potential cooperation between βcatenin and SP8 binding to
different Ccnd1 exon fragments (i.e., exon 5) needs further
investigation.
Our results show that SP8 is able to specifically activate gene
expression from the Ccnd1 Ex5 fragment. Consistently with our
luciferase results, we found a cluster of putative SP8 binding sites
at the end of the ORF in Ex5 fragment; this cluster overlapped
with the SP8 summit identified in our ChipSeq experiments
(Table S1 and Figure S2). These findings are very interesting as
they rise the possibility that SP8 might control gene expression
from binding to regions located at the 3′ end of the Ccnd1 gene in
addition to the classical enhancer/promoter regulative domains
located upstream of the target genes.
Human CCND1 3′UTR region has been shown to act as
a critical regulatory element. Different miRNAs are predicted
to bind human and mouse Ccnd1 3′UTR and regulate the
level of Cyclin D1 expression (Deshpande et al., 2009; Ghosh
et al., 2014); truncation or mutation of human CCND1 3′UTR
alter the stability of the CCND1 transcript activating its
oncogenic potential (Lebwohl et al., 1994; Molenaar et al.,
2003; Wiestner et al., 2007; Deshpande et al., 2009; Ghosh
et al., 2014). In addition, different Snps are present in the
3′UTR of mouse and human CCND1: Snp rs7178, localized
on CCND1 3′UTR, is involved in neuroblastoma (Wang
et al., 2011), and Snp rs7177, localized on CCND1 3′UTR,
is involved in cognitive behavior (Rietveld et al., 2013).
Considering that there is a 78.1% identity between human
and mouse Ccnd1 3′UTR (as revealed using the ECR Browser
Ovcharenko et al., 2004), these observations suggest a similar
role in gene regulation and neurogenesis for the mouse Ccnd1
3′UTR,
Our data, showing that SP8 binds and specifically regulates
Ccnd1 transcription from a region located at the end of the ORF
in exon 5 and close to the 3′UTR, suggest that the 3′-end of
the Ccnd1 gene may be a target of gene regulation at multiple
levels, including the transcriptional one. The in vitro validation
of the activity of SP8, as well as the interaction with PAX6 and
βcatenin on theCcnd1 locus, is based on an assay commonly used
to screen the activity of genomic regulative regions. In addition,
we provide further evidence based on manipulation of SP8 levels
of expression in vivo in GOF and LOF transgenic mice as well as
on RNAseq data that both clearly show a role for SP8 for Ccnd1
expression regulation at early stages of pallium development.
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In summary, multiple signals regulate Ccnd1 transcription
in mouse pallium during corticogenesis, resulting in a complex
pattern of Ccnd1 expression. SP8 appears as a major player in
this regulation, uncovering a potential novel role of the Sp-
transcription factor family in transcription regulation, which
awaits further analysis.
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Figure S1 | Predicted SP8 binding sites on Ccnd1 Ex1 fragment. The predicted
SP8 sites from Table S4 (A–G), the SP8 summit (SP8S), the PAX6 summit
(PAX6S), the predicted PAX6 binding site, and the ATG are indicated. The nt
positions refer to the Ccnd1 TSS1; SP8 (G) site position is indicated as 164 nt
downstream of the exon 1 ORF. The SP8 A-E sites are located in the promoter
region; SP8 (F,G) sites are the closest to the SP8 summit. Positions of the SP8S
and PAX6S are indicated in bold and underlined.
Figure S2 | Predicted SP8 binding sites on Ccnd1 Ex5 fragment. The 7 predicted
SP8 sites from Table S2 (A–G), the SP8 summit (SP8S), and the stop codon
(TGA) are indicated. The nt positions refer to the Ccnd1 TSS1; SP8 (A,B) position
is indicated as 125 nt upstream of the exon 5 ORF. Position of the SP8S is
indicated in bold and underlined.
Figure S3 | Pax6 and Axin2 expression at E12.5. ISH on E12.5 mouse
forebrain coronal sections. Panel (A) shows Pax6 expression in the rostral
forebrain and panel (B) shows Pax6 expression in a more caudal section,
panel (C) shows Axin2 expression, as proxy of the Wnt pathway activity, in the
rostral forebrain and panel (D) shows Axin2 expression in a more caudal
section. Bar in (A): 200µm.
Figure S4 | Sp8 expression analysis in the Sp8 LOF and GOF mutants at E12.5.
E12.5 mouse forebrain coronal sections. Sp8 mRNA expression levels are shown
in the control (A) and Sp8 LOF mutant (C), immunofluorescence of EGFP (B) is
shown as a proxy of Sp8 overexpression in the GOF mutant (Borello et al., 2014).
Bar in (A): 200µm.
Figure S5 | Genome-wide distribution of the SP8 binding sites on gene features.
Plot showing the percentage of the SP8 binding sites distributed genome-wide on
gene features.
Table S1 | SP8 and H3K27ac ChipSeq fragments identified on the Ccnd1 locus.
MACS results of the SP8 and H3K27ac ChipSeq peak calling. Position of the
peaks summits is indicated. The column “name” indicates the genomic fragment
names used in this study. The fragment named Ex1.2.3 in the H3K27ac ChipSeq
dataset contains Ccnd1 promoter, 5′UTR, and exons 1–3; fragment Ex5 contains
Ccnd1 exon 5 and 3′U TR.
Table S2 | Bioinformatic analysis using the Jaspar software (Mathelier et al., 2016)
of the Ccnd1 Ex5 fragment. Position of the predicted SP8 sites refers to the Ex5
fragment full sequence, nt 1-889.
Table S3 | Ccnd1 expression levels in the Sp8 GOF and LOF mutants. Results of
RNASeq analysis on Sp8 mutants obtained with DESeq2 (Love et al., 2014).
Table S4 | Bioinformatic analysis of the Ccnd1 Ex1 fragment using the Jaspar
software (Mathelier et al., 2016). Position of the predicted SP8 sites refers to the
Ex1 fragment full sequence, nt 1-1249. In bold are indicated the SP8 predicted
sites in the Ccnd1 promoter (SP8 A–E) showing the highest score values, and the
two SP8 sites (F,G) close to the position of the SP8 summit. The position of the
predicted PAX6 site is indicated.
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